While the second wave of COVID-19 in India is already a matter of concern, the emergence of new fungal infections associated with it is alarming. The estimated prevalence of mucormycosis in India is 70 times more than the global prevalence. The rise of mucormycosis cases in India has created a state of panic among the people.
Therefore, it is the doctors’ responsibility to educate their patients about the warning signs of mucormycosis, risk factors, prevention and treatment. In this regard, Docplexus presents a ‘Patient Education Kit’ that that will help your patients get a brief overview of mucormycosis. To download this kit, CLICK HERE Do let us know the additional topics that you may want to explore through such kits.
